Early MRI and outcomes of untreated patients with mild or improving ischemic stroke
- 26 September 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 67 (6), 980-984
- https://doi.org/10.1212/01.wnl.0000237520.88777.71
Abstract
To determine the frequency of early neurologic deterioration with infarct expansion (ENDIE) and poor outcomes among ischemic stroke patients not treated with reperfusion therapies because of rapidly improving or mild symptoms (RIMS) and to study the predictive value of hyperacute MRI in these patients. We identified consecutive patients with symptoms of acute stroke undergoing multimodal MRI within 6 hours of onset without evidence of hemorrhage on imaging. Medical records were reviewed for evidence of early neurologic deterioration within 48 hours. All deteriorating patients had repeat MRI to ascertain causes of worsening. Poor outcome was defined as a discharge modified Rankin Scale (mRS) score of > or = 3. We identified 74 patients with stroke symptoms < or = 6 hours from onset. Forty had RIMS, and 39 did not receive reperfusion therapies because of RIMS. Among these 39, 4 experienced ENDIE, and 8 were discharged with mRS score of > or = 3. Eight of the 39 patients had large-vessel occlusions on MR angiography. Three of 8 patients with large-vessel occlusion as against only one of 31 patients without occlusion had ENDIE (odds ratio [OR] 18, 95% CI 1.6 to 209, p = 0.02). Four of 8 patients with large-vessel occlusion as against 4 of 31 patients without occlusion had a discharge mRS score of > or = 3 (OR 7, 95% CI 1.2 to 38, p = 0.04). About 10% of patients eligible for acute reperfusion therapy excluded on the basis of mild or rapidly improving symptoms show early neurologic deterioration with infarct expansion within 48 hours, and about 20% show poor outcome at discharge. Persisting large-vessel occlusion substantially increases the risk of early worsening and poor functional outcome.Keywords
This publication has 11 references indexed in Scilit:
- Recombinant Tissue Plasminogen Activator for Minor Strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study ExperienceAnnals of Emergency Medicine, 2005
- Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic StrokeArchives of Neurology, 2004
- Preventive Antibacterial Treatment Improves the General Medical and Neurological Outcome in a Mouse Model of StrokeStroke, 2004
- Guidelines for the Early Management of Patients With Ischemic StrokeStroke, 2003
- Why are stroke patients excluded from TPA therapy?Neurology, 2001
- Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.Stroke, 2001
- Deterioration Following Spontaneous ImprovementStroke, 2000
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- State of the art medical management of acute ischemic strokeJournal Of Stroke & Cerebrovascular Diseases, 1997
- Spontaneous improvement after acute ischemic stroke. A pilot study.Stroke, 1990